Lensar (LNSR) Receivables - Other (2022 - 2025)

Lensar (LNSR) reported Receivables - Other of $38000.0 for Q2 2025, down 93.93% year-over-year from $626000.0 in Q2 2024, and down 73.61% quarter-over-quarter from $144000.0 in Q1 2025.

Lensar (LNSR) Receivables - Other (2022 - 2025) Analysis & Trends

Lensar (LNSR) has 4 years of Receivables - Other data on file, last reported at $38000.0 in Q2 2025.

  • Receivables - Other for Q2 2025 came in at $38000.0, down 93.93% year-over-year; the trailing twelve-month figure through Jun 2025 was $38000.0 (down 93.93% YoY), and the FY2024 annual result was $236000.0, down 75.97% from the prior year.
  • Receivables - Other slipped to $38000.0 in Q2 2025 per LNSR's latest filing, from $144000.0 in the prior quarter.
  • Over five years, Receivables - Other peaked at $982000.0 in Q4 2023 and troughed at $38000.0 in Q2 2025.
  • A 4-year average of $493333.3 and a median of $498500.0 in 2023 frame the typical range for Receivables - Other.
  • The sharpest annual moves came in 2023 and 2025: Receivables - Other jumped 1225.37% in 2023, then sank 93.93% in 2025.
  • A 4-year view of Receivables - Other shows it stood at $332000.0 in 2022, then soared by 195.78% to $982000.0 in 2023, then slumped by 75.97% to $236000.0 in 2024, then tumbled by 83.9% to $38000.0 in 2025.
  • Business Quant data shows LNSR's Receivables - Other at $38000.0 in Q2 2025, $144000.0 in Q1 2025, and $236000.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 Lensar 70.05 Mn 70.34 Mn 6.38 Mn

Historic Data

Download Data
DateValue
Jun 30, 2025 38,000.00
Jun 30, 2025 38,000.00
Mar 31, 2025 144,000.00
Mar 31, 2025 144,000.00
Dec 31, 2024 236,000.00
Dec 31, 2024 236,000.00
Sep 30, 2024 593,000.00
Sep 30, 2024 593,000.00
Jun 30, 2024 626,000.00
Jun 30, 2024 626,000.00
Mar 31, 2024 785,000.00
Mar 31, 2024 785,000.00
Dec 31, 2023 982,000.00
Dec 31, 2023 982,000.00
Sep 30, 2023 888,000.00
Sep 30, 2023 888,000.00
Jun 30, 2023 825,000.00
Jun 30, 2023 825,000.00
Mar 31, 2023 404,000.00
Mar 31, 2023 404,000.00